November 12, 2024

Cannabis and Psychosis

Although a few cannabinoid drugs have been approved by the Federal Drug Administration (FDA), cannabis has not been approved by the FDA for the treatment of any disease or condition. Therefore, physicians need to know the latest clinical trial information regarding the potential health benefits of cannabis use as well as epidemiologic data regarding potential health risks.
November 5, 2024

Lung Cancer

Lung Cancer is the second most common cancer in both men and women (not including skin cancer) and is by far the leading cause of cancer death. Overall, the chance of developing lung cancer is about 1 in 16 in men and 1 in 17 in women.
October 31, 2024

Dietary Sugars: The Good, The Bad, and The Ugly

Sugars and sweeteners are linked to a range of health risks.
October 29, 2024

Antimicrobial Resistance

Antimicrobial resistance is a growing public health threat worldwide.
October 21, 2024

Geriatric Polypharmacy

It is estimated that about one third of U.S adults in their 60s and 70s are using five or more prescription drugs.
October 4, 2024

Liver Cancer

About 41,630 new cases will be diagnosed in 2024, and about 29,840 people will die of this cancer.
October 1, 2024

ADHD

ADHD is one of the most common neurodevelopmental disorders of childhood.
September 23, 2024

Viral Respiratory Infections

Viral infections commonly affect the upper and lower respiratory tracts. Most viral respiratory infections are mild and don’t require treatment.
September 19, 2024

Neuropsychiatric Symptoms in Dementia

More than 90% of patients with dementia develop new-onset neuropsychiatric symptoms, including apathy, agitation, aggression, anxiety, depression, night-time behaviors, irritability, hallucinations, delusions, and motor symptoms. Being able to identify and treat these symptoms is paramount to dementia care. There are a few new pharmacological treatments that have emerged within the past 5 years that providers should be aware of, especially for agitation.